| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
| USP1 protein, partial | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 5 | 0 | 0 | 5 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| AR protein | 8 | 0 | 0 | 8 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| glucocorticoid receptor [Homo sapiens] | 5 | 0 | 0 | 5 |
| retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
| retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
| farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
| estrogen nuclear receptor alpha | 9 | 0 | 0 | 9 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 6 | 0 | 0 | 6 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| geminin | 7 | 0 | 0 | 7 |
| peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
| estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
| IDH1 | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 7 | 0 | 0 | 7 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 2 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
| Spike glycoprotein | 2 | 0 | 0 | 2 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| Nrf2 | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 2 | 0 | 0 | 2 |
| ATAD5 protein, partial | 3 | 0 | 0 | 3 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| GLS protein | 1 | 0 | 0 | 1 |
| TDP1 protein | 6 | 0 | 0 | 6 |
| aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| polyprotein | 1 | 0 | 0 | 1 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 1 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B10 | 0 | 2 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Pancreatic triacylglycerol lipase | 0 | 0 | 0 | 1 |
| Transthyretin | 0 | 0 | 2 | 2 |
| Estrogen receptor | 0 | 4 | 0 | 4 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 2 | 3 |
| Tyrosine-protein kinase Lck | 0 | 2 | 0 | 2 |
| Tyrosine-protein kinase Fyn | 0 | 4 | 0 | 4 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 1 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 1 | 0 | 4 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 1 | 0 | 4 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 1 | 0 | 4 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 1 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Alpha-synuclein | 1 | 1 | 0 | 2 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 1 | 0 | 4 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Integrase | 0 | 3 | 0 | 3 |
| GABA theta subunit | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 1 | 0 | 4 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
| Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
| Bile salt export pump | 0 | 8 | 0 | 8 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 2 | 0 | 2 |
| Leukotriene A-4 hydrolase | 0 | 2 | 1 | 3 |
| EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 3 | 1 | 4 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 3 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 1 | 1 |
| Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
| Succinyl-diaminopimelate desuccinylase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase TEM | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
| Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA gyrase subunit A | 0 | 1 | 0 | 3 |
| DNA gyrase subunit B | 0 | 1 | 0 | 3 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
| Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 4 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 3 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 3 |
| Luciferase | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
| progesterone receptor | 4 | 0 | 0 | 4 |
| pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
| peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| G | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| Interferon beta | 2 | 0 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
| Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 2 | 1 | 5 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
| Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Leukotriene C4 synthase | 0 | 1 | 0 | 1 |
| Cysteinyl leukotriene receptor 1 | 0 | 1 | 0 | 1 |
| Cysteinyl leukotriene receptor 2 | 0 | 1 | 0 | 1 |
| Cysteinyl leukotriene receptor 1 | 0 | 2 | 1 | 3 |
| cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 2 | 1 | 8 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 2 | 0 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| Interstitial collagenase | 0 | 1 | 0 | 1 |
| Transcription factor AP-1 | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Linoleate 9S-lipoxygenase-4 | 0 | 1 | 0 | 1 |
| UDP-galactopyranose mutase | 0 | 0 | 1 | 1 |
| Hyaluronidase-1 | 0 | 1 | 0 | 1 |
| UDP-galactopyranose mutase | 0 | 0 | 1 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |